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In a recent manuscript regarding the gendered impacts
of the COVID-19 outbreak, Wenham et al. (2020)
called the governments and global health institutions
of different countries to take some important actions.
First, as specified by these authors, the governments
and global health institutions should consider the sex
and gender effects of the COVID-19 outbreak
(Wenham et al. 2020). Second, the governments and
global health institutions should also conduct an analy-
sis of the gendered impacts of the multiple outbreaks
(Wenham et al. 2020). Lastly, they should incorporate
the voices of women on the front line of the response
to COVID-19 (Wenham et al. 2020). Over the last four
months, many different types of manuscripts regarding
specific aspects of the COVID-19 outbreak have been
published in PubMed and a lot of journals have called
works regarding this issue with “fast track decision”.
Given that, in science, gender disparity is an important
and recognized issue (Schwalbe and Fearon 2018;
Mathad et al. 2019; Shannon et al. 2019) (for instance,
the United Nations Educational, Scientific and Cultural
Organization’s Women in Science data has recently
demonstrated that ~30% of the world’s researchers were
women in 2018 [Mathad et al. 2019]), we have assessed
the percentages of female first and last authors among
all manuscripts on the COVID-19 outbreak available so
far. Searching in PubMed (which has a specific section
on COVID-19) from January 1st, 2020 to March 24th,
2020, we obtained 1448 items (namely, manuscripts).
We extracted information on the names of the first
and last authors in order to find if they were men or
women (by photos, information on ResearchGate or oth-
er websites), as well as information on journals. Of the
initial 1448 items, we excluded 312, as we were unable
to obtain the gender of the first and/or last authors ex-
actly. Hence, after this selection, the number of items
included in the final statistical analysis was 1136.
Table 1 summarizes the percentage of female re-
searchers among the first and last authors in all manu-
scripts on COVID-19 published up till March 24th,
2020. As reported, we found that 26.5% (95% confi-
dence interval 23.9–29.2%) of first authors were female
researchers and 25.3% (95% confidence interval 22.3–
28.4%) of last authors were women. No significant dif-
ference was observed when we stratified the manu-
scripts by journal rank (namely, impact factor < 10 vs.
impact factor ≥ 10) or journal country.
In a period characterized by the COVID-19 outbreak
and a “fast track” for the publication of manuscripts
regarding this severe problem, it again emerges that fe-
male researchers tend to publish much fewer manu-
scripts than men and that they are much less represented
in the relevant positions of manuscript authorships. In
this context, it is important to note that, to date, roughly
75% of trainees, health workers, and faculty involved in
global health are women (Mathad et al. 2019). Although
this is a novel topic that is affecting the whole world,
the gap in gender authorships is still evident in science.
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Indirectly, once again, these results may point out the
existence of barriers to the scientific career progress of
women. In fact, many obstacles might disincentivize
women from a scientific career, including organizational
constraints, sexual harassment, cultural prejudices, as
well as specific work and family requests (namely,
work–life balance) (Schwalbe and Fearon 2018;
Mathad et al. 2019; Shannon et al. 2019).
Our study has some important limitations that should
be mentioned. First, we were unable to obtain relevant
information including age, ethnicity, h-index, and years
spent working in science. Second, with respect to the ini-
tial selection, we had to exclude approximately 21% of
the initial items because we were unable to find the gen-
der of the first and/or last authors with certainty. Third,
the time interval of our research was relatively short.
In conclusion, gender equality is vital because it is able
to give health and benefits (Shannon et al. 2019). In fact,
several studies have recently documented that, in science,
gender equality improves innovation, productivity, quality,
and satisfaction (Shannon et al. 2019). Our study reports
that, also in this dramatic period, there is a gender gap in
science. Therefore, gender equality is not only an obliga-
tion of governments and global health institutions (as
correctly suggested by Wenham et al. 2020) but also a duty
of the scientific community.
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Table 1 Percentage of female
researchers among the first and
last authors of the manuscripts on




authors (n = 1136)
p-Values Percentage of female
researchers among last
authors (n = 1136)
p-Values
Overall 26.5% (23.9–29.2%) 25.3% (22.3–28.4%)
Manuscripts published
in journals with
IF < 10 (n = 826)
25.3% (22.3–28.4%) 0.246 22.3% (19.2–25.6%) 0.696
Manuscripts published
in journals with
IF ≥ 10 (n = 310)
29.7% (24.6–35.1%) 23.6% (17.7–30.3%)
Manuscripts published
in North American
journals (n = 339)












20.0% (2.5–55.6%) 75.0% (34.9–96.8%)
Manuscripts published
in international
journals (n = 12)
8.3% (0.3–38.5%) 50.7% (18.4–90.1%)
IF, impact factor. Data are expressed as percentages and 95% confidence intervals (in parentheses). p-Values were
calculated by the chi-squared test
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